Stock NUS NU SKIN ENTERPRISES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Nu Skin Enterprises, Inc. Swiss Exchange

Equities

NUS

US67018T1051

End-of-day quote Swiss Exchange
Other stock markets
 		5-day change 1st Jan Change
- CHF -.--% Intraday chart for Nu Skin Enterprises, Inc. -.--% -.--%
01/07 Nu Skin Enterprises, Inc.(NYSE:NUS) added to Russell 2000 Dynamic Index CI
09/05 DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating MT

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • With a P/E ratio at 12.08 for the current year and 7.69 for next year, earnings multiples are highly attractive compared with competitors.
  • The stock, which is currently worth 2024 to 0.42 times its sales, is clearly overvalued in comparison with peers.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
NU SKIN ENTERPRISES, INC. Stock Nu Skin Enterprises, Inc.
-.--% 55Cr -
PROCTER & GAMBLE COMPANY Stock Procter & Gamble Company
+12.74% 39TCr
C-
UNILEVER PLC Stock Unilever PLC
+13.92% 14TCr
B-
COLGATE-PALMOLIVE COMPANY Stock Colgate-Palmolive Company
+21.75% 7.96TCr
A+
HINDUSTAN UNILEVER LIMITED Stock Hindustan Unilever Limited
-4.36% 7.17TCr
A-
ESTEE LAUDER Stock Estee Lauder
-27.28% 3.81TCr
B+
KENVUE INC. Stock Kenvue Inc.
-14.96% 3.51TCr -
BEIERSDORF Stock Beiersdorf
+0.41% 3.3TCr
B-
ESSITY AB Stock Essity AB
+9.36% 1.83TCr
A-
GODREJ CONSUMER PRODUCTS LIMITED Stock Godrej Consumer Products Limited
+21.45% 1.68TCr
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NUS Stock
  4. NUS Stock
  5. Ratings Nu Skin Enterprises, Inc.